Fargesin is primarily studied for its biological activities and potential therapeutic applications. It exhibits anti-inflammatory properties by inhibiting the production of pro-inflammatory mediators such as nitric oxide and cytokines. This makes it a candidate for research in inflammatory diseases. It also shows vasodilatory effects, helping relax blood vessels, which may contribute to lowering blood pressure. Due to this activity, fargesin is investigated for cardiovascular health applications. In addition, fargesin has demonstrated anti-cancer potential in some studies, where it suppresses the growth of certain tumor cells by inducing cell cycle arrest and apoptosis. Research is ongoing in this area to understand its mechanism and potential use in oncology. The compound also possesses anti-platelet aggregation properties, meaning it may help prevent abnormal blood clotting, which is beneficial in reducing the risk of thrombotic events. Furthermore, fargesin is explored for its neuroprotective and antioxidant effects, suggesting possible applications in neurodegenerative disorders like Alzheimer’s disease. Most of the current applications are based on preclinical research, and further studies are needed to evaluate its efficacy and safety in humans.